Glucagonoma causes: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 10: Line 10:
==References==
==References==
{{reflist|2}}
{{reflist|2}}
 
{{WH}}
[[Category:Disease]]
{{WS}}
[[Category:Types of cancer]]
[[Category:Medicine]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Revision as of 15:37, 12 October 2017

Glucagonoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Glucagonoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Glucagonoma causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Glucagonoma causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Glucagonoma causes

CDC on Glucagonoma causes

Glucagonoma causes in the news

Blogs on Glucagonoma causes

Directions to Hospitals Treating Glucagonoma

Risk calculators and risk factors for Glucagonoma causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

There are no established causes for glucagonoma. Mostly, glucagonomas are sporadic but 20% are associated with the MEN1 syndrome.

Causes

There are no established causes for glucagonoma. Mostly, glucagonomas are sporadic but 20% are associated with the MEN1 syndrome.[1][2]

References

  1. Lévy-Bohbot N, Merle C, Goudet P, Delemer B, Calender A, Jolly D, Thiéfin G, Cadiot G (2004). "Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry". Gastroenterol. Clin. Biol. 28 (11): 1075–81. PMID 15657529.
  2. Glucagonoma. U.S. National Library of Medicine. https://www.nlm.nih.gov/medlineplus/ency/article/000326.htm

Template:WH Template:WS